2009
DOI: 10.1017/s1461145709000388
|View full text |Cite
|
Sign up to set email alerts
|

Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation

Abstract: Neuregulin 1 (Nrg1) has been widely recognized as a candidate gene for schizophrenia. This study therefore investigated mice heterozygous for a mutation in the transmembrane domain of this trophic factor (Nrg1+/- mice) in a number of behavioural test systems with relevance to schizophrenia, including psychotropic drug-induced locomotor hyperactivity and prepulse inhibition (PPI) of startle. Baseline locomotor activity in the open field or in photocell cages was slightly, but significantly enhanced in Nrg1+/- m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
64
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
4

Relationship

2
8

Authors

Journals

citations
Cited by 88 publications
(67 citation statements)
references
References 40 publications
3
64
0
Order By: Relevance
“…They also showed PPI and LI disruptions, as well as increased drug-dependent disruption of PPI, but no spatial memory deficits. 263,268,269 No differences were reported in terms of DA or serotonin receptor numbers. 269 These mouse models are consistent with the literature on schizophrenia in humans and elucidate some possible schizophrenia-related biomarkers that can now be specifically examined in human patients.…”
Section: Neuregulin-1 (Nrg1)mentioning
confidence: 99%
“…They also showed PPI and LI disruptions, as well as increased drug-dependent disruption of PPI, but no spatial memory deficits. 263,268,269 No differences were reported in terms of DA or serotonin receptor numbers. 269 These mouse models are consistent with the literature on schizophrenia in humans and elucidate some possible schizophrenia-related biomarkers that can now be specifically examined in human patients.…”
Section: Neuregulin-1 (Nrg1)mentioning
confidence: 99%
“…Mice were given an injection dose of 0.5 mg/kg. The drug dosage used was based on previous studies showing a high locomotor response with little stereotypic or ataxic behaviours [44,45].…”
Section: Psychomimetic Drugsmentioning
confidence: 99%
“…[15,32]). In our study, hyperlocomotion was accompanied by decreased resting behaviour in baseline conditions and increased distance travelled in the periphery post restraint stress.…”
Section: R Chesworth Et Al / Neuroscience Letters 515 (2012) 82-86mentioning
confidence: 99%